ACI submits tox data to FSA

Compliance CBD novel food

The Association for the Cannabinoid Industry (ACI) submitted a complete toxicological package to the Food Standards Agency (FSA) on Friday, 4 November 2022, to support members’ novel food applications. These applications account for 33% of the applications made to the FSA, and align to approximately half of the products identified on the public list. Currently […]

EFSA reveals several areas of concern in novel food applications

The European Food Safety Authority (EFSA) has found several key areas of concern in novel food submissions it has received for CBD.   Among the areas of primary concern are missing information on applications and data gaps, which would support the evaluation of safety profiles, according to information shared during an EFSA-led webinar on 29 June.  […]

FSA issues final call for ingestible CBD products

26 may FSA issues final call

The Food Standards Agency (FSA) has issued a final call for ingestible CBD products to be added to the public list. The register of consumable CBD products was revealed on 31 March and comprises 3,536 products. Only those on the list have a credible application for authorisation with the FSA and as a result are […]

UK CBD sector on standby for release of FSA’s list of permitted products

The UK’s consumer health sector is set for its biggest shake-up in more than a decade when the Food Standards Agency (FSA) releases its eagerly-awaited public list of CBD products permitted for sale to consumers. Only products on the list will be able to stay on the market, while those not included will have to […]

FSA issues clarification and new deadline for toxicology data

A number of CBD companies have until 28 February to provide sufficient toxicology data to the Food Standards Agency, or risk losing the right to sell their products.  Cannabinoid Insight has learnt that up to 40 CBD companies which submitted summary data on epilepsy drug Epidiolex in their novel foods application, have until 28 February […]